In April 2024 Bristol ESG were asked to complete a short report on psychosocial interventions for adults with harmful use of psychostimulants (NIHR167860).
Project details
This project summarized the findings from a recently published Cochrane review, “Psychosocial interventions for stimulant use disorder” (Minozzi et al, 2024). A critical appraisal and applicability assessment of the review for the question posed by the policy customer was also conducted, using the ROBIS tool. Minozzi 2024 focused on clinical effectiveness and safety outcomes and did not include economic outcomes. As such, we extended the searches to identify additional trial-based, full economic evaluation publications linked to any of the 64 randomized controlled trials included by Minozzi et al. Cost effectiveness findings from each study were reported narratively.